A xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical uses.

Human adipose stem cells (HASCS) play a crucial role in the fields of regenerative medicine and tissue engineering for different reasons: the abundance of adipose tissue, their easy harvesting, the ability to multipotent differentiation and the fact that they do not trigger allogeneic blood response...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Carmen Escobedo-Lucea, Carmen Bellver, Carolina Gandia, Andres Sanz-Garcia, Francisco J Esteban, Vicente Mirabet, Giancarlo Forte, Isabel Moreno, Melissa Lezameta, Angel Ayuso-Sacido, José M Garcia-Verdugo
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4ed7592beb7242c18f5584cc21519488
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4ed7592beb7242c18f5584cc21519488
record_format dspace
spelling oai:doaj.org-article:4ed7592beb7242c18f5584cc215194882021-11-18T07:38:13ZA xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical uses.1932-620310.1371/journal.pone.0067870https://doaj.org/article/4ed7592beb7242c18f5584cc215194882013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23874459/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Human adipose stem cells (HASCS) play a crucial role in the fields of regenerative medicine and tissue engineering for different reasons: the abundance of adipose tissue, their easy harvesting, the ability to multipotent differentiation and the fact that they do not trigger allogeneic blood response or secrete cytokines that act as immunosuppressants. The vast majority of protocols use animal origin reagents, with the underlying risk of transmitting infections by non-human pathogens. We have designed a protocol to isolate and maintain the properties of hASCs avoiding xenogeneic reagents. These changes not only preserve hASCs morphology, but also increase cell proliferation and maintain their stem cell marker profile. On the other hand, human serum albumin (HSA), Tryple® and human Serum (HS), do not affect hASCs multipotent differentiation ability. The amendments introduced do not trigger modifications in the transcriptional profile of hASCs, alterations in key biochemical pathways or malignization. Thus, we have proven that it is possible to isolate and maintain hASCs avoiding animal reagents and, at the same time, preserving crucial culture parameters during long term culture. Thereby we have revealed a novel and effective tool for the improvement of clinical, cell-based therapies.Carmen Escobedo-LuceaCarmen BellverCarolina GandiaAndres Sanz-GarciaFrancisco J EstebanVicente MirabetGiancarlo ForteIsabel MorenoMelissa LezametaAngel Ayuso-SacidoJosé M Garcia-VerdugoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 7, p e67870 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Carmen Escobedo-Lucea
Carmen Bellver
Carolina Gandia
Andres Sanz-Garcia
Francisco J Esteban
Vicente Mirabet
Giancarlo Forte
Isabel Moreno
Melissa Lezameta
Angel Ayuso-Sacido
José M Garcia-Verdugo
A xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical uses.
description Human adipose stem cells (HASCS) play a crucial role in the fields of regenerative medicine and tissue engineering for different reasons: the abundance of adipose tissue, their easy harvesting, the ability to multipotent differentiation and the fact that they do not trigger allogeneic blood response or secrete cytokines that act as immunosuppressants. The vast majority of protocols use animal origin reagents, with the underlying risk of transmitting infections by non-human pathogens. We have designed a protocol to isolate and maintain the properties of hASCs avoiding xenogeneic reagents. These changes not only preserve hASCs morphology, but also increase cell proliferation and maintain their stem cell marker profile. On the other hand, human serum albumin (HSA), Tryple® and human Serum (HS), do not affect hASCs multipotent differentiation ability. The amendments introduced do not trigger modifications in the transcriptional profile of hASCs, alterations in key biochemical pathways or malignization. Thus, we have proven that it is possible to isolate and maintain hASCs avoiding animal reagents and, at the same time, preserving crucial culture parameters during long term culture. Thereby we have revealed a novel and effective tool for the improvement of clinical, cell-based therapies.
format article
author Carmen Escobedo-Lucea
Carmen Bellver
Carolina Gandia
Andres Sanz-Garcia
Francisco J Esteban
Vicente Mirabet
Giancarlo Forte
Isabel Moreno
Melissa Lezameta
Angel Ayuso-Sacido
José M Garcia-Verdugo
author_facet Carmen Escobedo-Lucea
Carmen Bellver
Carolina Gandia
Andres Sanz-Garcia
Francisco J Esteban
Vicente Mirabet
Giancarlo Forte
Isabel Moreno
Melissa Lezameta
Angel Ayuso-Sacido
José M Garcia-Verdugo
author_sort Carmen Escobedo-Lucea
title A xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical uses.
title_short A xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical uses.
title_full A xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical uses.
title_fullStr A xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical uses.
title_full_unstemmed A xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical uses.
title_sort xenogeneic-free protocol for isolation and expansion of human adipose stem cells for clinical uses.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/4ed7592beb7242c18f5584cc21519488
work_keys_str_mv AT carmenescobedolucea axenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT carmenbellver axenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT carolinagandia axenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT andressanzgarcia axenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT franciscojesteban axenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT vicentemirabet axenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT giancarloforte axenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT isabelmoreno axenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT melissalezameta axenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT angelayusosacido axenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT josemgarciaverdugo axenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT carmenescobedolucea xenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT carmenbellver xenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT carolinagandia xenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT andressanzgarcia xenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT franciscojesteban xenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT vicentemirabet xenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT giancarloforte xenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT isabelmoreno xenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT melissalezameta xenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT angelayusosacido xenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
AT josemgarciaverdugo xenogeneicfreeprotocolforisolationandexpansionofhumanadiposestemcellsforclinicaluses
_version_ 1718423157943042048